Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN)
- Resource Type
- Article
- Source
- In
Gynecologic Oncology August 2023 175:66-71 - Subject
- Language
- ISSN
- 0090-8258